as on September 16, 2025 at 1:29 am IST
Day's Low
3.61%
Downside
52 Week's Low
52 Week's High
45.28%
Downside
1.04%
Upside
Check Theravance Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$720.2M
EPS (TTM)
-0.15
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
59.58
Industry PE ratio
-3.8535542168674697
P/B Ratio
59.5833
PEG Ratio
-0.05
EBITDA
-34.0M
Revenue (TTM)
77.2M
Profit Margin
16.88%
Return On Equity TTM
6.23%
Track how Theravance Biopharma Inc P/E has moved over time to understand its valuation trends.
Theravance Biopharma Inc in the last 5 years
Lowest (24.89x)
June 30, 2025
Industry (-3.85x)
September 15, 2025
Today (59.58x)
September 15, 2025
Highest (24.89x)
June 30, 2025
Today’s Price to Earnings Ratio: 59.58x
Compare market cap, revenue, PE, and other key metrics of Theravance Biopharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $720.2M | -19.8% | 59.58 | 16.88% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Theravance Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Theravance Biopharma Inc investment value today
Current value as on today
₹1,81,890
Returns
₹81,890
(+81.89%)
Returns from Theravance Biopharma Inc Stock
₹76,904 (+76.9%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Theravance Biopharma Inc. Average target price of $20
Get share price movements and forecasts by analysts on Theravance Biopharma Inc.
What analysts predicted
28%UPSIDE
Target Price
$20
Current Price
$14.4
Analyzed by
11 Analysts
Target
$20.00
Theravance Biopharma Inc target price $20, a slight upside of 28% compared to current price of $14.4. According to 11 analysts rating.
Search interest for Theravance Biopharma Inc Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:50% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, TBPH has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 3 months, TBPH stock has moved up by 33.8%
Revenue Rich
Revenue is up for the last 2 quarters, 15.38M → 26.19M (in $), with an average increase of 41.3% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, -15.52M → 54.83M (in $), with an average increase of 69.6% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 81.2%
Organisation | Theravance Biopharma Inc |
Headquarters | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Mr. Rick E. Winningham M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Stuart Knight | Senior VP of IT&I and Chief Information Officer |
Ms. Rhonda F. Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs |
Ms. Stacy L. Pryce | Senior VP & Chief Strategy Officer |
Dr. Aine Miller Ph.D. | Senior VP of Development & Head of Ireland Office |
Mr. Rick E. Winningham M.B.A. | CEO & Director |
Mr. Aziz Sawaf C.F.A. | Senior VP & CFO |
Mr. Brett A. Grimaud Esq. | Senior VP, General Counsel & Secretary |
Theravance Biopharma Inc share price today is $14.4 as on at the close of the market. Theravance Biopharma Inc share today touched a day high of $14.4 and a low of $13.88.
Theravance Biopharma Inc share touched a 52 week high of $14.55 on and a 52 week low of $7.88 on . Theravance Biopharma Inc stock price today i.e. is closed at $14.4,which is 1.03% down from its 52 week high and 82.74% up from its 52 week low.
Theravance Biopharma Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Theravance Biopharma Inc (TBPH) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Theravance Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Theravance Biopharma Inc share’s latest price of $14.4 as on September 16, 2025 at 1:29 am IST, you will get 0.6944 shares of Theravance Biopharma Inc. Learn more about
fractional shares .
Theravance Biopharma Inc stock has given -19.8% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?